BRPI0415725A - formulação aspergìvel transdérmica, método para administrar um agente farmaceuticamente ativo e método para formar uma pelìcula farmaceuticamente ativa - Google Patents
formulação aspergìvel transdérmica, método para administrar um agente farmaceuticamente ativo e método para formar uma pelìcula farmaceuticamente ativaInfo
- Publication number
- BRPI0415725A BRPI0415725A BRPI0415725-7A BRPI0415725A BRPI0415725A BR PI0415725 A BRPI0415725 A BR PI0415725A BR PI0415725 A BRPI0415725 A BR PI0415725A BR PI0415725 A BRPI0415725 A BR PI0415725A
- Authority
- BR
- Brazil
- Prior art keywords
- pharmaceutically active
- active agent
- administering
- forming
- film
- Prior art date
Links
- 238000009472 formulation Methods 0.000 title abstract 6
- 239000000203 mixture Substances 0.000 title abstract 6
- 239000013543 active substance Substances 0.000 title abstract 5
- 238000000034 method Methods 0.000 title abstract 5
- 230000002821 anti-nucleating effect Effects 0.000 abstract 1
- 229920001577 copolymer Polymers 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000002687 nonaqueous vehicle Substances 0.000 abstract 1
- 239000002667 nucleating agent Substances 0.000 abstract 1
- 239000003961 penetration enhancing agent Substances 0.000 abstract 1
- 238000001953 recrystallisation Methods 0.000 abstract 1
- 239000007930 transdermal spray Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Dispersion Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
"FORMULAçãO ASPERGìVEL TRANSDéRMICA, MéTODO PARA ADMINISTRAR UM AGENTE FARMACEUTICAMENTE ATIVO E MéTODO PARA FORMAR UMA PELìCULA FARMACEUTICAMENTE ATIVA". São providos formulações aspergíveis transdérmicas contendo um agente farmaceuticamente ativo e métodos para administrar as mesmas. As formulações compreendem o agente farmaceuticamente ativo, um copolímero de VP/AV e um veículo não aquoso. As formulações compreendem ainda um agente anti-nucleante para evitar a recristalização do agente farmaceuticamente ativo e um intensificador de penetração para aumentar a taxa de liberação do fármaco através da pele. Quando da aplicação da pele, a presente formulação seca para prover uma película no local de tratamento.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN1122MU2003 | 2003-10-23 | ||
| PCT/GB2004/004487 WO2005041943A1 (en) | 2003-10-23 | 2004-10-21 | Transdermal pharmaceutical spray formulations comprising a vp/va copolymer and a non-aqueous vehicle |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0415725A true BRPI0415725A (pt) | 2006-12-19 |
Family
ID=34531861
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0415725-7A BRPI0415725A (pt) | 2003-10-23 | 2004-10-21 | formulação aspergìvel transdérmica, método para administrar um agente farmaceuticamente ativo e método para formar uma pelìcula farmaceuticamente ativa |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US20070219171A1 (pt) |
| EP (1) | EP1686969A1 (pt) |
| JP (1) | JP2007509122A (pt) |
| CN (1) | CN100431531C (pt) |
| AP (1) | AP2006003628A0 (pt) |
| AR (1) | AR046146A1 (pt) |
| AU (1) | AU2004285335B2 (pt) |
| BR (1) | BRPI0415725A (pt) |
| CA (1) | CA2543245A1 (pt) |
| IL (1) | IL175094A0 (pt) |
| MA (1) | MA28167A1 (pt) |
| MX (1) | MXPA06004460A (pt) |
| NO (1) | NO20062234L (pt) |
| NZ (1) | NZ547376A (pt) |
| PA (1) | PA8615501A1 (pt) |
| PE (1) | PE20050443A1 (pt) |
| RU (1) | RU2006117527A (pt) |
| SM (1) | SM200400022A (pt) |
| SV (1) | SV2006001916A (pt) |
| TW (1) | TW200524635A (pt) |
| WO (1) | WO2005041943A1 (pt) |
| ZA (1) | ZA200604036B (pt) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0518769D0 (en) * | 2005-09-14 | 2005-10-19 | Medpharm Ltd | Topical formulations |
| CA2719512A1 (en) | 2010-11-01 | 2012-05-01 | Stiefel Research Australia Pty Ltd | Polymeric topical compositions |
| CN102018671B (zh) * | 2011-01-05 | 2012-07-25 | 浙江大学 | 一种雌二醇透皮喷雾剂及其制备方法 |
| US20150065449A1 (en) * | 2011-08-12 | 2015-03-05 | Florida State University Research Foundation, Inc. | Treating Amyloidoses With A Vitamin B12 Composition Including Melatonin, Resveratrol, and EGCG |
| GB201200062D0 (en) | 2012-01-04 | 2012-02-15 | Innotesto Bvba | Estradiol oromucosal liquid compositions |
| TWI516281B (zh) * | 2014-07-16 | 2016-01-11 | 健維生技有限公司 | 改良之睪固酮製劑製法及所得之睪固酮製劑 |
| AU2016359706B2 (en) | 2015-11-23 | 2022-07-28 | Acasti Pharma U.S., Inc. | Topical film-forming spray |
| WO2019140087A1 (en) * | 2018-01-10 | 2019-07-18 | Celista Pharmaceuticals Llc | Testosterone transdermal spray with film |
| ES3053765T3 (en) | 2018-07-05 | 2026-01-26 | Celista Pharmaceuticals Llc | Testosterone and estradiol transdermal spray |
| CN109432061B (zh) * | 2018-11-09 | 2020-10-30 | 北京德默高科医药技术有限公司 | 含有布洛芬或其结构类似物的多层经皮给药系统 |
| CN115154661A (zh) * | 2022-07-29 | 2022-10-11 | 广州莱度品牌管理有限公司 | 一种仿生角质膜的制备方法 |
| CN118593475B (zh) * | 2024-06-06 | 2025-07-25 | 暨南大学 | 用于治疗帕金森病的组合物、鼻喷雾剂及其制备方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3868248D1 (de) * | 1987-05-27 | 1992-03-12 | Burghart Kurt | Transdermal therapeutisch wirkende pharmazeutische zubereitung sowie vorrichtung zum aufbringen der zubereitung. |
| FR2732223B1 (fr) * | 1995-03-30 | 1997-06-13 | Sanofi Sa | Composition pharmaceutique pour administration transdermique |
| FR2739031B1 (fr) * | 1995-09-27 | 1997-11-21 | Lhd Lab Hygiene Dietetique | Systeme matriciel transdermique d'administration d'un oestrogene et/ou d'un progestatif a base de copolymere styrene-isoprene-styrene, procede de preparation et utilisation en therapeutique |
| IT1299566B1 (it) * | 1998-07-17 | 2000-03-16 | Ifi Istituto Farmacoterapico I | Cerotto transdermico e composizioni farmaceutiche comprendenti r (-)- norapropilapomorfina cloridrato e/o s (+) - norapropilapomorfina |
| RO121628B1 (ro) * | 1999-02-05 | 2008-01-30 | Cipla Limited | Compoziţie medicinală, topică, pulverizabilă,dozator care o conţine, procedeu de realizare a dozatorului şi utilizarea compoziţiei menţionate |
| US6962691B1 (en) * | 1999-05-20 | 2005-11-08 | U & I Pharmaceuticals Ltd. | Topical spray compositions |
| US6274167B1 (en) * | 2000-09-14 | 2001-08-14 | Vincent Margiotta | Topical anesthetic patch |
| US6528040B1 (en) * | 2001-01-18 | 2003-03-04 | Maurine Pearson | EMU oil-based formulations for use as an analgesic, anesthetic and antipruritic |
| DE10211832A1 (de) * | 2002-03-16 | 2003-10-02 | Lohmann Therapie Syst Lts | Hormonhaltiges transdermales therapeutisches System mit einem Wirkstoffreservoir auf der Basis von Vinylacetat-Vinylpyrrolidon-Copolymer mit verbesserter Kohäsion |
-
2004
- 2004-10-21 JP JP2006536176A patent/JP2007509122A/ja active Pending
- 2004-10-21 MX MXPA06004460A patent/MXPA06004460A/es unknown
- 2004-10-21 CN CNB2004800382138A patent/CN100431531C/zh not_active Expired - Fee Related
- 2004-10-21 AP AP2006003628A patent/AP2006003628A0/xx unknown
- 2004-10-21 CA CA002543245A patent/CA2543245A1/en not_active Abandoned
- 2004-10-21 BR BRPI0415725-7A patent/BRPI0415725A/pt not_active Application Discontinuation
- 2004-10-21 RU RU2006117527/15A patent/RU2006117527A/ru not_active Application Discontinuation
- 2004-10-21 ZA ZA200604036A patent/ZA200604036B/en unknown
- 2004-10-21 WO PCT/GB2004/004487 patent/WO2005041943A1/en not_active Ceased
- 2004-10-21 US US10/576,908 patent/US20070219171A1/en not_active Abandoned
- 2004-10-21 EP EP04769002A patent/EP1686969A1/en not_active Withdrawn
- 2004-10-21 AU AU2004285335A patent/AU2004285335B2/en not_active Ceased
- 2004-10-21 NZ NZ547376A patent/NZ547376A/xx not_active IP Right Cessation
- 2004-10-22 PE PE2004001017A patent/PE20050443A1/es not_active Application Discontinuation
- 2004-10-22 AR ARP040103859A patent/AR046146A1/es unknown
- 2004-10-22 SV SV2004001916A patent/SV2006001916A/es not_active Application Discontinuation
- 2004-10-22 SM SM200400022A patent/SM200400022A/it unknown
- 2004-10-22 TW TW093132292A patent/TW200524635A/zh unknown
- 2004-10-22 PA PA20048615501A patent/PA8615501A1/es unknown
-
2006
- 2006-04-23 IL IL175094A patent/IL175094A0/en unknown
- 2006-05-18 NO NO20062234A patent/NO20062234L/no not_active Application Discontinuation
- 2006-05-23 MA MA29045A patent/MA28167A1/fr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PE20050443A1 (es) | 2005-06-14 |
| AU2004285335B2 (en) | 2011-02-10 |
| SV2006001916A (es) | 2006-03-16 |
| NO20062234L (no) | 2006-06-30 |
| RU2006117527A (ru) | 2007-12-10 |
| IL175094A0 (en) | 2006-08-20 |
| ZA200604036B (en) | 2007-09-26 |
| SM200400022B (it) | 2005-08-24 |
| SM200400022A (it) | 2005-08-24 |
| HK1098351A1 (zh) | 2007-07-20 |
| KR20070000397A (ko) | 2007-01-02 |
| CN100431531C (zh) | 2008-11-12 |
| AP2006003628A0 (en) | 2006-06-30 |
| TW200524635A (en) | 2005-08-01 |
| PA8615501A1 (es) | 2005-10-25 |
| CN1897927A (zh) | 2007-01-17 |
| US20070219171A1 (en) | 2007-09-20 |
| MXPA06004460A (es) | 2006-06-27 |
| NZ547376A (en) | 2009-07-31 |
| WO2005041943A1 (en) | 2005-05-12 |
| AR046146A1 (es) | 2005-11-23 |
| JP2007509122A (ja) | 2007-04-12 |
| AU2004285335A1 (en) | 2005-05-12 |
| EP1686969A1 (en) | 2006-08-09 |
| CA2543245A1 (en) | 2005-05-12 |
| MA28167A1 (fr) | 2006-09-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2733812T3 (es) | Polímeros acrílicos que contienen silicona para composiciones de administración transdérmica de fármacos | |
| KR100640039B1 (ko) | 세르타코나졸을 포함하며, 손발톱의 기능장애와 질환을치료하기 위한 플라스터 | |
| AR033066A1 (es) | Metodo para controlar la liberacion de ingredientes activos agricolas desde semillas de plantas tratadas | |
| US20100267678A1 (en) | Flux-enabling compositions and methods for dermal delivery of drugs | |
| JP5542665B2 (ja) | マトリックス型経皮投与剤およびその製造方法 | |
| NO20043871L (no) | Legemiddelformuleringer med kontrollert frigjoring som inneholder et baererpeptid | |
| ATE323473T1 (de) | Pharmazeutische zusammensetzungen enthaltend resveratrol und verwendungen davon | |
| BR0312007A (pt) | Controle de taxa de administração transcutânea usando composições farmacêuticas amorfas | |
| BRPI0415725A (pt) | formulação aspergìvel transdérmica, método para administrar um agente farmaceuticamente ativo e método para formar uma pelìcula farmaceuticamente ativa | |
| BRPI0407485A (pt) | utilização de anticorpos anti-receptores de factor crescimento i semelhantes aos anti-insulina | |
| BR9913154A (pt) | Composição de musse | |
| BRPI0508933A (pt) | composições para entrega tópica | |
| TW200616650A (en) | Semi-solid delivery vehicle and pharmaceutical compositions | |
| KR20150136077A (ko) | 국소 조성물 및 국소 질환의 치료 방법 | |
| JP2005503318A (ja) | 医薬組成物 | |
| EA200501819A1 (ru) | Способы и фармацевтические композиции для достоверного достижения приемлемых уровней тестостерона в сыворотке | |
| BRPI0117180B8 (pt) | composição farmacêutica em uma forma de unidade sólida de dosagem para a administração oral a um ser humano ou animal inferior | |
| BRPI0417437A (pt) | dispositivo para inibição da absorção, dispositivo para remoção de agente fisiologicamente ativo e dispositivo para redução do efeito de overdose | |
| WO2007022090A3 (en) | Topical delivery with a carrier fluid | |
| AR001790A1 (es) | Formulaciones para parches transdermicos que sirven para el tratamiento de condiciones modeladas de receptores muscarinicos | |
| DK1280558T3 (da) | Halvfast indgivelsesvehikel og farmaceutiske sammensætninger | |
| DK1300143T3 (da) | Plaster som indeholder 4-biphenyleddikesyre | |
| JP2016513665A5 (pt) | ||
| BR0312004A (pt) | Composições de aerossol transdérmicas | |
| JO2492B1 (en) | A pharmaceutical formula in the form of aqueous gel for the skin use of its active ingredients |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B11A | Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing | ||
| B11Y | Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette] |